Tag Archives: Drive

Precision medicine as a way to improve oncology care — and potentially drive down drug costs

Broadly defined, precision medicine is about the personalization of care. Yet on a practical level, precision medicine can take on different forms in different subspecialties in healthcare. In modern oncology care, it’s largely about getting the right drugs to the right patient at the right time. There’s also some early evidence that more efficient targeted… Read More »

Increased Payer and Provider Support May Drive Billions of Dollars in Savings from Biosimilars

By SHEILA FRAME  FDA Commissioner Scott Gottlieb has said biosimilars are “key to promoting access and reducing health care costs. And it’s a key to advancing public health.” While the Administration works to reduce barriers to bringing biosimilars to market, payers and providers can help increase adoption of biosimilars in clinical practice and ensure cost… Read More »